MedPath
FDA Approval

Gemfibrozil

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 11, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Gemfibrozil(600 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

NuCare Pharmaceutical, Inc.

NuCare Pharmaceuticals, Inc.

010632300

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Gemfibrozil

Product Details

NDC Product Code
66267-436
Application Number
ANDA077836
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 11, 2021
CALCIUM STEARATEInactive
Code: 776XM7047LClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQClass: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
METHYLCELLULOSE (15 CPS)Inactive
Code: NPU9M2E6L8Class: IACT
HYPROMELLOSE 2910 (3 MPA.S)Inactive
Code: 0VUT3PMY82Class: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6Class: IACT
Code: Q8X02027X3Class: ACTIBQuantity: 600 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath